Breast cancer report 29 April 2022_Design_Page_1

Improve breast cancer trial design and execution

A global analysis of 2.5 million breast cancer patients 

Participants in breast cancer clinical trials are getting younger and the clinical trial landscape has become more complex as more comprehensive biomarker combinations have been identified.  Find out the implications for trial design and execution. 

Download our report and learn about:

  • The impact of changing demographics
  • The industry's move to more tailored, effective treatments
  • Key biomarker trends 
  • Opportunities for digital twins and synthetic control arms 

Download your free report